Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCEA vs PCA for Recovery After Major Gynecologic Surgery
NCT00136682Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2004
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain and postoperative ileus (POI) (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Pain at rest and when coughing. Started Aug 2004; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative painpostoperative ileus (POI)
Beyond the preview
Go deeper on NCT00136682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136682.